|
⚲
|
| Keyboard |
| Kelly Leanne
✚
|
|
|---|---|
| CIK # | 0001398278 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001398278] | |
| 4 | [0001398278] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kelly Leanne | |
| GRI Bio Inc | |
| Windtree Therapeutics Inc /DE/ |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
GRI Bio Inc GRI
Stock Option (Right to Buy) · derivative
|
2025-01-23 | Grant | 43,319 | $0.69 | 29,890 |
|
GRI Bio Inc GRI
Stock Option (Right to Buy) · derivative
|
2023-09-22 | Grant | 83,333 | $1.52 | 126,666 |
|
GRI Bio Inc VLON
Stock Option (Right to Buy) · derivative
|
2022-02-15 | Grant | 50,000 | $5.63 | 281,500 |
|
GRI Bio Inc VLON
Common Stock
|
2021-06-04 | Buy | 1,508 | $4.08 | 6,153 |
|
GRI Bio Inc VLON
Common Stock
|
2021-06-03 | Buy | 1,085 | $4.05 | 4,394 |
|
GRI Bio Inc VLON
Common Stock
|
2021-06-02 | Buy | 3,657 | $4.00 | 14,628 |
|
GRI Bio Inc VLON
Stock Option (Right to Buy) · derivative
|
2021-05-14 | Grant | 70,000 | $0.00 |